MedicalSystem Biotechnology Co., Ltd. (300439) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

MedicalSystem Biotechnology Co., Ltd.

Why is MedicalSystem Biotechnology Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of -10.30% and Operating profit at 15.24% over the last 5 years

The company has declared negative results for the last 2 consecutive quarters

NET SALES(HY) At CNY 761.64 MM has Grown at -17.68%
ROCE(HY) Lowest at 3.22%
INVENTORY TURNOVER RATIO(HY) Lowest at 3.61 times

Below par performance in long term as well as near term

Along with generating -17.27% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is MedicalSystem Biotechnology Co., Ltd. for you?

Medium Risk, Low Return

Absolute

Risk Adjusted

Volatility

MedicalSystem Biotechnology Co., Ltd.

-14.3%

-0.03

30.15%

China Shanghai Composite

13.33%

0.90

14.74%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-10.30%

EBIT Growth (5y)

15.24%

EBIT to Interest (avg)

24.44

Debt to EBITDA (avg)

Net Debt is too low

Net Debt to Equity (avg)

-0.25

Sales to Capital Employed (avg)

0.62

Tax Ratio

6.81%

Dividend Payout Ratio

20.02%

Pledged Shares

Institutional Holding

ROCE (avg)

9.78%

ROE (avg)

8.27%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.34

EV to EBIT

39.42

EV to EBITDA

9.94

EV to Capital Employed

1.48

EV to Sales

2.02

PEG Ratio

Dividend Yield

1.31%

ROCE (Latest)

3.75%

ROE (Latest)

4.74%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bullish

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Mildly Bullish

Bearish

Dow Theory

Mildly Bearish

OBV

No Trend

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company

NO KEY POSITIVE TRIGGERS

-35What is not working for the Company

NET SALES(HY)

At CNY 761.64 MM has Grown at -17.68%

ROCE(HY)

Lowest at 3.22%

INVENTORY TURNOVER RATIO(HY)

Lowest at 3.61 times

OPERATING PROFIT MARGIN(Q)

Lowest at -1.77 %

RAW MATERIAL COST(Y)

Grown by 10.1% (YoY

INTEREST(Q)

Highest at CNY 1.04 MM

OPERATING PROFIT(Q)

Lowest at CNY -7.06 MM

PRE-TAX PROFIT(Q)

Lowest at CNY -4.47 MM

NET PROFIT(Q)

Lowest at CNY 3.03 MM

EPS(Q)

Lowest at CNY 0.01

Here's what is not working for MedicalSystem Biotechnology Co., Ltd.

Pre-Tax Profit

At CNY -4.47 MM has Fallen at -113.44%

over average net sales of the previous four periods of CNY 33.3 MM

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CNY MM)

Net Profit

At CNY 3.03 MM has Fallen at -91.12%

over average net sales of the previous four periods of CNY 34.09 MM

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (CNY MM)

Net Sales

At CNY 761.64 MM has Grown at -17.68%

Year on Year (YoY)

MOJO Watch

Near term sales trend is very negative

Net Sales (CNY MM)

Interest

At CNY 1.04 MM has Grown at inf%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Operating Profit Margin

Lowest at -1.77 % and Fallen

In each period in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Inventory Turnover Ratio

Lowest at 3.61 times and Fallen

In each half year in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Interest

Highest at CNY 1.04 MM

in the last five periods and Increased by inf% (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Operating Profit

Lowest at CNY -7.06 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Pre-Tax Profit

Lowest at CNY -4.47 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (CNY MM)

Net Profit

Lowest at CNY 3.03 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is negative

Net Profit (CNY MM)

EPS

Lowest at CNY 0.01

in the last five periods

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (CNY)

Raw Material Cost

Grown by 10.1% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales